Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 3 5Phase 1 5Phase 1/2 4Phase 2/3 2Phase EARLY_PHASE1 1

Status

Active not recruiting 10Recruiting 5Completed 5

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Genitourinary 1

Conditions

Carcinoma, Hepatocellular 3Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × tremelimumab × Clear all
NCT06921785 2026-05-11

ARTEMIDE-HCC01

AstraZeneca

Phase 3 Recruiting
1,220 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04585490 2026-05-04

Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC

Stanford University

Phase 3 Recruiting
48 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07166406 2026-05-04

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

NRG Oncology

Phase 3 Recruiting
226 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05557838 2025-02-07

TREMENDOUS

AstraZeneca

Phase 3 Recruiting
210 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03288532 2020-09-07

RAMPART

University College, London

Phase 3 Recruiting
1,750 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡